Impact of opioid use on dentistry

Australian Dental Journal

Volumn 47, Issue 2, 2002, Pages 94-98

  Titsas, A ^a   Ferguson, M M ^b  

^a University of Otago ^*  (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Infection; Methadone; Morphine; Opioid; Tooth

Indexed keywords

METHADONE; NARCOTIC AGENT;

ADOLESCENT; ADULT; DENTAL ANXIETY; DENTAL CARE; DENTAL CARIES; FEMALE; HUMAN; MALE; MOUTH DISEASE; OPIATE ADDICTION; OPPORTUNISTIC INFECTION; PERIODONTAL DISEASE; PSYCHOLOGICAL ASPECT; REVIEW; SOCIAL BEHAVIOR; TOOTH DISEASE;

ADOLESCENT; ADULT; DENTAL ANXIETY; DENTAL CARE FOR DISABLED; DENTAL CARIES; FEMALE; HUMANS; MALE; METHADONE; MOUTH DISEASES; NARCOTICS; OPIOID-RELATED DISORDERS; OPPORTUNISTIC INFECTIONS; PERIODONTAL DISEASES; SOCIAL BEHAVIOR; TOOTH DISEASES;

EID: 0036617729     PISSN: 00450421     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1834-7819.2002.tb00311.x     Document Type: Review

References (54)

1. Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gillman A, eds. Goodman and Gillman's The Pharmacological Basis of Therapeutics. 9th edn. New York: McGraw Hill, 1996:521-555.
2. O'Brien CP. Drug addiction and drug abuse. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gillman A, eds. Goodman and Gillman's The Pharmacological Basis of Therapeutics. 9th edn. New York: McGraw Hill, 1996:557-577.
3. Department of Health, Housing and Community Services, Statistics on drug abuse in Australia 1992. Canberra: Australian Government Publishing Service, 1992.
4. Black S, Cresswell S. Drugs in NZ - A survey 1990. Alcohol and Public Health Research Unit, Auckland University. 1991.
5. National Protocol for Methadone Programmes in New Zealand. Drug Advisory Committee: Department of Health. New Zealand. 1992.
6. Ward J, Mattick RP, Hall W. Key Issues In Methadone Maintenance Treatment. Glebe: New South Wales University Press, 1992.
7. New Zealand survey of methadone treatment: May-October 1992. In Methadone Treatment Information. Drugs Advisory Committee, 1992.
8. Gossop M, Marsden J, Stewart D, et al. Substance use, health and social problems of service users at 54 drug treatment agencies. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry 1998;173:166-171.
9. Healey A, Knapp M, Astin J, et al. Economic burden of drug dependency. Social costs incurred by drug users at intake to the National Treatment Outcome Research Study. Br J Psychiatry 1998;173:160-165.
10. Wodak A. Managing illicit drug use. A practical guide. Drugs 1994;47:446-457.
11. Mirin SM, Weiss RD, Michael J, Griffin ML. Psychopathology in substance abusers: diagnosis and treatment. Am J Drug Alcohol Abuse 1988;14:139-157.
12. Levinson I, Galykner II, Rosenthal RN. Methadone withdrawal psychosis. J Clin Psychiatry 1995;56:73-76.
13. Affinnih YH. A preliminary study of drug abuse and its mental health and health consequences among addicts in Greater Accra, Ghana. J Psychoactive Drugs 1999;31:395-403.
14. Brienza RS, Stein MD, Chen M, et al. Depression among needle exchange program and methadone maintenance clients. J Subst Abuse Treat 2000;18:331-337.
15. Santolaria-Fernandez FJ, Gomez-Sirvent JL, Gonzalez-Reimers JN, et al. Nutritional assessment of drug addicts. Drug Alcohol Depend 1995;38:11-18.
16. Rhodes T, Quirk A. Drug users' sexual relationships and the social organization of risk: the sexual relationship as a site of risk management. Soc Sci Med 1998;46:157-169.
17. Passeri LA, Ellis E, Sinn DP. Relationship of substance abuse to complications with mandibular fractures. J Oral Maxillofac Surg 1993;51:22-25.
18. Chetwynd J, Brunton C, Blank M, Plumridge E, Baldwin D. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme. NZ Med J 1995;108:364-366.
19. Ogilvie EL, Veit F, Crofts N, Thompson SC. Hepatitis infection among adolescents resident in Melbourne Juvenile Justice Centre: risk factors and challenges. J Adolesc Health 1999;25:46-51.
20. Ribera E, Miro JM, Cortes E, et al. Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 1998;158:2043-2050.
21. Molis ME, Watson RR, Leonard-Green T. Nutritional effects of marijuana, heroin, cocaine, and nicotine. J Am Diet Assoc 1990;90:1261-1267.
22. Govitrapong P, Suttitum T, Kotchabhakdi N, Uneklabh T. Alterations of immune functions in heroin addicts and heroin withdrawal subjects. J Pharmacol Exp Ther 1998;286:883-889.
23. Ryan CF, White JM. Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire. Addiction 1996;91:39-45.
24. Tobutt C, Oppenheimer E, Laranjeira R. Health of cohort of heroin addicts from London clinics: 22 year follow up. BMJ 1996;312:1458.
25. Rees TD. Oral effects of drug abuse. Crit Rev Oral Biol Med 1992;3:163-184.
26. Sheedy JJ. Methadone and caries. Case reports. Aust Dent J 1996;41:367-369.
27. Fazzi M, Vescovi P, Savi A, Manfredi M, Peracchia M. The effects of drugs on the oral cavity. Minerva Stomatol 1999;48:485-492.
28. Carr KD, Papadouka V. The role of multiple opioid receptors in the potentiation of reward by food restriction. Brain Res 1994;639:253-260.
29. Badiani A, Leone P, Noel MB, Stewart J. Ventral tegmental area opioid mechanisms and modulation of ingestive behaviour. Brain Res 1995;670:264-276.
30. Zador D, Lyons Wall PM, Webster I. High sugar intake in a group of women on methadone maintenance in South Western Sydney, Australia. Addiction 1996;91:1053-1061.
31. Morabia A, Fabre J, Chee E, Zeger S, Orsat E, Robert A. Diet and opiate addiction: a quantitative assessment of the diet of non-institutionalized opiate addicts. Br J Addict 1989;84:173-180.
32. Odeh M, Oliven A, Bassan H. Morphine and severe dryness of the lips- Postgrad Med J 1992;68:303-304.
33. Darke S, Ross J. The use of antidepressants among injecting drug users in Sydney, Australia. Addiction 2000;95:407-417.
34. Meaney PJ. Methadone and caries. Aust Dent J 1997;42:138-139.
35. Angelillo IF, Grasso GM, Villari P, D'Errico MM. Dental health in a group of drug addicts in Italy. Community Dent Oral Epidemiol 1991;19:36-37.
36. Davis RK, Baer PN. Necrotizing ulcerative gingivitis in drug addict patients being withdrawn from drugs: Report of two cases. Oral Surg Oral Med Oral Pathol 1971;31:200-204.
37. Szabo I, Rojavin M, Bussiere JL, Eisenstein TK, Adler MW, Rogers TJ. Suppression of peritoneal macrophage phagycotosis of Candida albicans by opioids. J Pharmacol Exp Ther 1993;267:703-706.
38. Ishikawa M, Tanno K, Kamo A, Takayanagi Y, Sasaki K. Enhancement of tumor growth by morphine and its possible mechanism in mice. Biol Pharm Bull 1993;16:762-766.
39. Llewelyn J, Mitchell R. Smoking, alcohol and oral cancer in south east Scotland: a 10-year experience. Br J Oral Maxillofac Surg 1994;32:146-152.
40. Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP, Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst 1998;90:1198-1205.
41. Endicot JN, Skipper P, Hernandez L. Marijuana and head and neck cancer. Adv Exp Med Biol 1993;335:107-113.
42. Colon PG Jr. Dental disease in the narcotic addict. Oral Surg Oral Med Oral Pathol 1972;33:905-910.
43. Hartmann EM. Alcohol and bruxism. N Engl J Med 1979;301:333.
44. Darke S, Sims J, McDonald S, Wickes W. Cognitive impairment among methadone maintenance patients. Addiction 2000;95:687-695.
45. Scheutz F. Anxiety and dental fear in a group of parenteral drug addicts. Scand J Dent Res 1986;94:241-247.
46. Tennant F, Shannon JA, Nork JG, Sagherian A, Berman M. Abnormal adrenal gland metabolism in opioid addicts: implications for clinical treatment. J Psychoactive Drugs 1991;23:135-149.
47. Council on dental practice: Chemical dependency and dental practice. J Am Dent Assoc 1987;114:509-515.
48. Friedlander AH, Mills MJ. The dental management of the drug-dependent patient. Oral Surg Oral Med Oral Pathol 1985;60:489-492.
49. Randell S, Libman RH. Outpatient intravenous sedation for a dental patient with narcotic addiction -report of a case. Anesth Prog 1976;23:28-30.
50. Gillespie J, Kronish AD, Dubin R. Anesthetic management for dentistry in patients on methadone maintenance. Anesth Prog 1980;27:85-87.
51. Sadeghi P, Zancy JP. Anesthesia is a risk factor for drug and alcohol craving and relapse in ex-abusers. Med Hypotheses 1999;53:490-496.
52. Haverkos HW, Lange WR. From the Alcohol, Drug Abuse, and Mental Health Administration. Serious infections other than human immunodeficiency virus among intravenous drug abusers. J Infect Dis 1990;161:894-902.
53. Pallasch TJ, Slots J. Antibiotic prophylaxis and the medically compromised patient. Periodontol 2000. 1996;10:107-138.
54. Cook H, Peoples J, Paden M. Management of the oral surgery patient addicted to heroin. J Oral Maxillofac Surg 1989;47:281-285.